Women’s evaluation of pain during insertion3*

Women experienced:

18.5%

no pain

(268/1452)

47.0%

mild pain

(638/1452)

27.5%

moderate pain

(400/1452)

6.9%

severe pain

(100/1452)

Almost two thirds (65.5%) of women in the study experienced no pain or mild pain.

There was a trend towards less pain in parous women compared to nulliparous women.3

* Results from a multi-centre international, open-label, randomized clinical study for 3 years with an extension to 5 years in 1,452 women aged 18-35 evaluating the contraceptive efficacy of Kyleena® (levonorgestrel-releasing intrauterine system [19.5 mg]).